Success Metrics

Clinical Success Rate
88.2%

Based on 30 completed trials

Completion Rate
88%(30/34)
Active Trials
10(17%)
Results Posted
53%(16 trials)
Terminated
4(7%)

Phase Distribution

Ph not_applicable
7
12%
Ph phase_3
3
5%
Ph phase_1
26
45%
Ph phase_2
16
28%
Ph early_phase_1
4
7%

Phase Distribution

30

Early Stage

16

Mid Stage

3

Late Stage

Phase Distribution56 total trials
Early Phase 1First-in-human
4(7.1%)
Phase 1Safety & dosage
26(46.4%)
Phase 2Efficacy & side effects
16(28.6%)
Phase 3Large-scale testing
3(5.4%)
N/ANon-phased studies
7(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

30 of 36 finished

Non-Completion Rate

16.7%

6 ended early

Currently Active

10

trials recruiting

Total Trials

58

all time

Status Distribution
Active(15)
Completed(30)
Terminated(6)
Other(7)

Detailed Status

Completed30
Recruiting9
unknown5
Not yet recruiting4
Terminated4
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
58
Active
10
Success Rate
88.2%
Most Advanced
Phase 3

Trials by Phase

Early Phase 14 (7.1%)
Phase 126 (46.4%)
Phase 216 (28.6%)
Phase 33 (5.4%)
N/A7 (12.5%)

Trials by Status

withdrawn23%
completed3052%
recruiting916%
not_yet_recruiting47%
terminated47%
active_not_recruiting12%
enrolling_by_invitation12%
suspended23%
unknown59%

Recent Activity

Clinical Trials (58)

Showing 20 of 58 trialsScroll for more
NCT07216690Phase 2

Pregnenolone as a Treatment for Cannabis Intoxication

Recruiting
NCT07214155Phase 1

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

Not Yet Recruiting
NCT06137365Phase 2

Cannabis for Obesity Trial

Not Yet Recruiting
NCT05563948Phase 2

Repeated Administration of Cannabis Varying in THC and CBD

Suspended
NCT05602649Phase 1

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

Recruiting
NCT07498023Phase 1

EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)

Active Not Recruiting
NCT04325958Not Applicable

Age Differences in the Effects of Cannabis on Simulated Driving

Recruiting
NCT05526196Not Applicable

Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes

Recruiting
NCT06351540Phase 1

Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance

Not Yet Recruiting
NCT07417059Not Applicable

Sex Hormones Impact on Cannabis Response

Recruiting
NCT05999383Phase 2

Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration

Recruiting
NCT05865470Phase 1

Age-dependent Effects of Smoked and Oral Delta-9-THC

Recruiting
NCT03734731Not Applicable

Cannabis Vs Opioids Pain Management Objective Testing Comparisons

Not Yet Recruiting
NCT05488509Phase 2

Acute Effects of Cannabis on Everyday Life Memory

Completed
NCT06259916Not Applicable

Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)

Recruiting
NCT03633721Phase 2

Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women

Completed
NCT04931095Phase 1

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

Completed
NCT06293040Phase 1

Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment

Recruiting
NCT03948074Phase 2

Cannabis For Cancer-Related Symptoms

Completed
NCT03766971Phase 2

Influence of Tobacco Use on Cannabis Use

Suspended

Drug Details

Intervention Type
DRUG
Total Trials
58